{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:03:49Z","timestamp":1790697829182,"version":"4.1.0"},"reference-count":15,"publisher":"Academy of Managed Care Pharmacy","issue":"10-c Suppl","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.18553\/jmcp.2026.32.10-c.s3","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:17:12Z","timestamp":1790695032000},"page":"S11-S20","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the definition of unmet medical need: Findings from a multistakeholder workshop"],"prefix":"10.18553","volume":"32","author":[{"given":"Antal","family":"Zemplenyi","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"DiStefano","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanke","family":"Zheng","sequence":"additional","affiliation":[{"name":"National Pharmaceutical Council, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Campbell","sequence":"additional","affiliation":[{"name":"National Pharmaceutical Council, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Brett","family":"McQueen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7818","reference":[{"key":"r1","unstructured":"FDA.\n                      Expedited Programs for Serious Conditions \u2013 Drugs and Biologics\n                      . 2023. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/expedited-programs-serious-conditions-drugs-and-biologics"},{"key":"r2","unstructured":"Centers for Medicare & Medicaid Services. Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price Applicability Year 2026. August 2023. https:\/\/www.cms.gov\/files\/document\/fact-sheet-medicare-selected-drug-negotiation-list-ipay-2026.pdf"},{"key":"r3","unstructured":"Seshamani M. Medicare Drug Price Negotiation Program: Final Guidance, Implementation of Sections 1191\u20131198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price in 2026 and 2027. 2024. https:\/\/www.cms.gov\/files\/document\/medicare-drug-price-negotiation-final-guidance-ipay-2027-and-manufacturer-effectuation-mfp-2026-2027.pdf"},{"key":"r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.07.007"},{"key":"r5","unstructured":"Levine A, Kowal S, Kowal S. Improving How CMS Defines \u201cUnmet Medical Need\u201d Under The IRA.\n                      Health Affairs Forefront\n                      . 2024. https:\/\/www.healthaffairs.org\/content\/forefront\/improving-cms-defines-unmet-medical-need-under-ira"},{"key":"r6","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-025-01009-z"},{"key":"r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.09.2910"},{"key":"r8","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2018-0102"},{"key":"r9","doi-asserted-by":"publisher","DOI":"10.1006\/obhd.1994.1087"},{"key":"r10","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-021-00655-3"},{"key":"r11","doi-asserted-by":"publisher","DOI":"10.1017\/S1744133119000161"},{"key":"r12","doi-asserted-by":"publisher","DOI":"10.1007\/s10728-018-0361-2"},{"key":"r13","unstructured":"PCORI. PCORI Methodology Standards. April 9, 2024. https:\/\/www.pcori.org\/research-related-projects\/about-our-research\/research-methodology\/pcori-methodology-standards#Associated%20with%20Patient-Centeredness"},{"key":"r14","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2024.23255"},{"key":"r15","unstructured":"IQVIA Institute for Human Data Science. Impacts of the Proliferation of Innovation: Characterizing Post-Launch Drug Development, Unmet Need, and the Potential Implications of Medicare Price Negotiations. IQVIA Institute; 2024. https:\/\/www.iqvia.com\/insights\/the-iqvia-institute\/reports-and-publications\/reports\/impacts-of-the-proliferation-of-innovation"}],"container-title":["Journal of Managed Care &amp; Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:17:14Z","timestamp":1790695034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2026.32.10-c.s3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":15,"journal-issue":{"issue":"10-c Suppl","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.18553\/jmcp.2026.32.10-c.s3"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2026.32.10-c.s3","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}